BioSpace News Archive

Spectrum Pharmaceuticals (NasdaqGS: SPPI) a biopharmaceutical company focused on novel and targeted oncology therapies, today announced it will host a conference call to discuss the third quarter 2020 financial results and provide a corporate update on Wednesday, November 4, 2020 at 4:30 p.m. Eastern/1:30 p.m. Pacific. Conference Call and Webcast: Wednesday, November 4, 2020 @ 4:30 p.m. Eastern/1:30 p.m. P

Expertly annotated patient samples from world-class clinical research facility Samples used to advance development of the world’s first 3D genomic severity test for COVID-19 disease built using the EpiSwitch™ platform Goal is to provide insight into a wide range of COVID-19 responses, from mild to severe Adds to Oxford BioDynamics’ growing bank of 500+ procured samples from cohorts around the world

Finch Therapeutics Presents Data from Its Positive PRISM3 Trial of CP101 in Recurrent C. difficile Infection at Two Leading Medical Conferences PRISM3 data presented at the annual meetings of the United European Gastroenterology and the American College of Gastroenterology Late-breaker oral presentations expand on previously announced positive topline data showing that CP101 met the primary efficacy endpoint with statistically significant improv

Only HER2-directed medicine to demonstrate significant improvement in overall survival compared to chemotherapy for previously treated patients in this setting

insitro Announces Five-Year Discovery Collaboration with Bristol Myers Squibb to Discover and Develop Novel Treatments for Amyotrophic Lateral Sclerosis and Frontotemporal Dementia insitro to Receive $50 Million in Upfront Cash with Total Potential Deal Value Over $2.1 Billion Collaboration to Advance Targets and Therapeutic Candidates SAN FRANCISCO--( BUSINESS WIRE )-- insitro, a machine-learning driven drug discovery and development compan

Kroger Health’s new offering will help inform patients if they have recently been infected with the virus that causes COVID-19, with most results confirmed in 15 minutes

Saphetor, a global precision medicine company and the creator of VarSome, the emerging global standard platform for human genome data, announced a partnership with Roche Turkey.

Otonomy, Inc. (Nasdaq: OTIC), a biopharmaceutical company dedicated to the development of innovative therapeutics for neurotology, today announced it will report financial results for the third quarter of 2020 and provide a corporate update at 4:30 p.m. ET on November 4, 2020. The live call may be accessed by dialing (877) 305-6769 for domestic callers and (678) 562-4239 for international callers with conference ID code number: 5179918. A live web

XOMA Corporation (Nasdaq: XOMA) announced today NIS793, an anti-TGFβ monoclonal antibody licensed from XOMA, has advanced to the Phase 2 development stage, triggering a $25 million milestone payment from Novartis.

As healthcare facilities across Mississippi resume scheduling routine appointments and screenings, Magnolia Health (Magnolia) wants to remind communities of the importance of taking care of their health.